How the Dana Farber Cancer Institute treats young patients with multiple myeloma

Myeloma experts at the Dana Farber Cancer center discuss how they approach the treatment of young patients with multiple myeloma in an article published online in Blood. The treatment landscape for multiple myeloma has been transformed by the introduction of novel agents, including immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies. These have been shown to be … Continue reading How the Dana Farber Cancer Institute treats young patients with multiple myeloma